Effects of the BDNF val66met polymorphism on prefrontal brain function in a population at high genetic risk of schizophrenia

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 8, 2010, Pages 1474-1482

  Whalley, Heather C ^a   Baig, Benjamin J ^a   Hall, Jeremy ^a   Job, Dominic E ^a   McIntosh, Andrew M ^a   Cunningham Owens, David G ^a   Johnstone, Eve C ^a   Lawrie, Stephen M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

BDNF; Cingulate; FMRI; Schizophrenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; VALINE;

ADULT; ARTICLE; BRAIN FUNCTION; DNA POLYMORPHISM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; PATHOPHYSIOLOGY; POPULATION RESEARCH; PREFRONTAL CORTEX; PRIORITY JOURNAL; RELATIVE; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TASK PERFORMANCE;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; BRAIN MAPPING; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; RISK; SCHIZOPHRENIA; YOUNG ADULT;

EID: 78851468963     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31128     Document Type: Article

References (85)

1. Aguilera M, Arias B, Wichers M, Barrantes-Vidal N, Moya J, Villa H, Van Os J, Ibanez MI, Ruiperez MA, Ortet G, et al. 2009. Early adversity and 5-HTT/BDNF genes: New evidence of gene-environment interactions on depressive symptoms in a general population. Psychol Med 39: 1425-1432.
2. Alleva E, Francia N. 2009. Psychiatric vulnerability: Suggestions from animal models and role of neurotrophins. Neurosci Biobehav Rev 33(4): 525-536.
3. Baiano M, David A, Versace A, Churchill R, Balestrieri M, Brambilla P. 2007. Anterior cingulate volumes in schizophrenia: A systematic review and a meta-analysis of MRI studies. Schizophr Res 93(1-3): 1-12.
4. Bath KG, Lee FS. 2006. Variant BDNF (Val66Met) impact on brain structure and function. Cogn Affect Behav Neurosci 6(1): 79-85.
5. Bekinschtein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, Goldin A, Izquierdo I, Medina JH. 2008. BDNF is essential to promote persistence of long-term memory storage. Proc Natl Acad Sci USA 105(7): 2711-2716.
6. Bloom PA, Fischler I. 1980. Completion norms for 329 sentence contexts. Mem Cognit 8: 631-642.
7. Burgess P, Shallice T. 1997. The Hayling and Brixton Tests. Bury, St Edmunds: Thames Valley Test Company Limited.
8. Bush G, Luu P, Posner MI. 2000. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 4: 215-222.
9. Chen ZY, Patel PD, Gayatree S, Meng CX, Teng K, Hempstead BL, Lee FS. 2004. Variant brain-derived neurotrophic factor (BDNF) (Met 66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 24(18): 4401-4411.
10. Curtis VA, Bullmore ET, Brammer MJ, Wright IC, Williams SC, Morris RG, Sharma TS, Murray RM, McGuire PK. 1998. Attenuated frontal activation during a verbal fluency task in patients with schizophrenia. Am J Psychiatry 155: 1056-1063.
11. Durany N, Thome J. 2004. Neurotrophic factors and the pathophysiology of schizophrenic psychoses. Eur Psychiatry 19: 326-337.
12. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, et al. 2003. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function [see comment]. Cell 112(2): 257-269.
13. Fornito A, Yung AR, Wood SJ, Phillips LJ, Nelson B, Cotton S, Velakoulis D, McGorry PD, Pantelis C, Yucel M. 2008. Anatomic abnormalities of the anterior cingulate cortex before psychosis onset: An MRI study of ultra-high-risk individuals. Biol Psychiatry 64(9): 758-765.
14. Frith CD, Friston KJ, Herold S, Silbersweig D, Fletcher P, Cahill C, Dolan RJ, Frackowiak RS, Liddle PF. 1995. Regional brain activity in chronic schizophrenic patients during the performance of a verbal fluency task. Br J Psychiatry 167(3): 343-349.
15. Fu CH, Suckling J, Williams SC, Andrew CM, Vythelingum GN, McGuire PK. 2005. Effects of psychotic state and task demand on prefrontal function in schizophrenia: An fMRI study of overt verbal fluency. Am J Psychiatry 162(3): 485-494.
16. Fusar-Poli P, Perez J, Broome M, Borgwardt S, Placentino A, Caverzasi E, Cortesi M, Veggiotti P, Politi P, Barale F, et al. 2007. Neurofunctional correlates of vulnerability to psychosis: A systematic review and meta-analysis. Neurosci Biobehav Rev 31(4): 465-484.
17. Gallinat J, Schubert F, Bruhl R, Hellweg R, Klar AA, Kehrer C, Wirth C, Sander T, Lang UE. 2010. Met carriers of BDNF Val66Met genotype show increased N-acetylaspartate concentration in the anterior cingulate cortex. Neuroimage 49: 767-771.
18. Glahn DC, Ragland JD, Abramoff A, Barrett J, Laird AR, Bearden CE, Velligan DI. 2005. Beyond hypofrontality: A quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia. Hum Brain Mapp 25(1): 60-69.
19. Glahn DC, Laird AR, Ellison-Wright I, Thelen SM, Robinson JL, Lancaster JL, Bullmore E, Fox PT. 2008. Meta-analysis of gray matter anomalies in schizophrenia: Application of anatomic likelihood estimation and network analysis. Biol Psychiatry 64(9): 774-781.
20. Hall J, Whalley HC, McKirdy JW, Romaniuk L, McGonigle DJ, McIntosh AM, Baig BJ, Gountouna VE, Job DE, Donaldson DL, et al. 2008. Overactivation of fear systems to neutral faces in schizophrenia. Biol Psychiatry 64(1): 70-73.
21. Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, Egan MF, Weinberger DR. 2003. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 23(17): 6690-6694.
22. Harrison BJ, Yucel M, Pujol J, Pantelis C. 2007. Task-induced deactivation of midline cortical regions in schizophrenia assessed with fMRI. Schizophr Res 91(1-3): 82-86.
23. Hashimoto T, Bergen SE, Nguyen QL, Xu B, Monteggia LM, Pierri JN, Sun Z, Sampson AR, Lewis DA. 2005. Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J Neurosci 25(2): 372-383.
24. Heinrichs RW, Zakzanis KK. 1998. Neurocognitive deficit in schizophrenia: A quantitative review of the evidence. Neuropsychology 12(3): 426-445.
25. Ho BC, Andreasen NC, Dawson JD, Wassink TH. 2007. Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am J Psychiatry 164(12): 1890-1899.
26. Hodges A, Byrne M, Grant E, Johnstone E. 1999. People at risk of schizophrenia. Sample characteristics of the first 100 cases in the Edinburgh High-Risk Study [see comment]. Br J Psychiatry 174: 547-553.
27. Hong CJ, Yu YW, Lin CH, Tsai SJ. 2003. An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci Lett 349(3): 206-208.
28. Job DE, Whalley HC, McConnell S, Glabus M, Johnstone EC, Lawrie SM. 2002. Structural gray matter differences between first-episode schizophrenics and normal controls using voxel-based morphometry. Neuroimage 17(2): 880-889.
29. Job DE, Whalley HC, McConnell S, Glabus M, Johnstone EC, Lawrie SM. 2003. Voxel-based morphometry of grey matter densities in subjects at high risk of schizophrenia. Schizophr Res 64(1): 1-13.
30. Johnstone EC, Abukmeil SS, Byrne M, Clafferty R, Grant E, Hodges A, Lawrie SM, Owens DG. 2000. Edinburgh High Risk Study-Findings after four years: Demographic, attainment and psychopathological issues. Schizophr Res 46(1): 1-15.
31. Jonsson EG, Edman-Ahlbom B, Sillen A, Gunnar A, Kulle B, Frigessi A, Vares M, Ekholm B, Wode-Helgodt B, Schumacher J, et al. 2006. Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: An association study. Progr Neuro-Psychopharmacol Biol Psychiatry 30(5): 924-933.
32. Kay SR, Fiszbein A, Opler LA. 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2): 261-276.
33. Lawrie SM, Abukmeil SS. 1998. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies [see comment]. Br J Psychiatry 172: 110-120.
34. Lawrie SM, Buechel C, Whalley HC, Frith CD, Friston KJ, Johnstone EC. 2002. Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations. Biol Psychiatry 51(12): 1008-1011.
35. Lencz T, Lipsky RH, DeRosse P, Burdick KE, Kane JM, Malhotra AK. 2009. Molecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypes. Br J Psychiatry 194: 313-318.
36. Lu B. 2003. BDNF and activity-dependent synaptic modulation. Learn Mem 10(2): 86-98.
37. Lu B, Chow A. 1999. Neurotrophins and hippocampal synaptic transmission and plasticity. J Neurosci Res 58(1): 76-87.
38. McGuffin P, Farmer A, Harvey I. 1991. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry 48(8): 764-770.
39. McIntosh AM, Baig BJ, Hall J, Job D, Whalley HC, Lymer GK, Moorhead TW, Owens DG, Miller P, Porteous D, et al. 2007. Relationship of catechol-O-methyltransferase variants to brain structure and function in a population at high risk of psychosis [see comment]. Biol Psychiatry 61(10): 1127-1134.
40. Meisenzahl EM, Koutsouleris N, Bottlender R, Scheuerecker J, Jager M, Teipel SJ, Holzinger S, Frodl T, Preuss U, Schmitt G, et al. 2008. Structural brain alterations at different stages of schizophrenia: A voxel-based morphometric study. Schizophr Res 104(1-3): 44-60.
41. Minzenberg MJ, Laird AR, Thelen S, Carter CS, Glahn DC. 2009. Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Arch Gen Psychiatry 66(8): 811-822.
42. Muller DJ, de Luca V, Sicard T, King N, Strauss J, Kennedy JL. 2006. Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: Family-based association study. Br J Psychiatry 189: 317-323.
43. Nagel IE, Chicherio C, Li S-C, von Oertzen T, Sander T, Villringer A, Heekeren HR, Backman L, Lindenberger U. 2008. Human aging magnifies genetic effects on executive functioning and working memory. Front Hum Neurosci 2(1): 1-8.
44. Naoe Y, Shinkai T, Hori H, Fukunaka Y, Utsunomiya K, Sakata S, Matsumoto C, Shimizu K, Hwang R, Ohmori O, et al. 2007. No association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and schizophrenia in Asian populations: Evidence from a case-control study and meta-analysis. Neurosci Lett 415(2): 108-112.
45. Nemoto K, Ohnishi T, Mori T, Moriguchi Y, Hashimoto R, Asada T, Kunugi H. 2006. The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neurosci Lett 397(1-2): 25-29.
46. Neuhaus AH, Koehler S, Opgen-Rhein C, Urbanek C, Hahn E, Dettling M. 2007. Selective anterior cingulate cortex deficit during conflict solution in schizophrenia: An event-related potential study. J Psychiatr Res 41(8): 635-644.
47. Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, Breen G, Yates P, Sinclair M, Crombie C, Walker N, St Clair DM. 2005. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 10(2): 208-212.
48. Numata S, Ueno S, Iga J, Yamauchi K, Hongwei S, Ohta K, Kinouchi S, Shibuya-Tayoshi S, Tayoshi S, Aono M, et al. 2006. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neurosci Lett 401(1-2): 1-5.
49. O'Donovan MC, Williams NM, Owen MJ. 2003. Recent advances in the genetics of schizophrenia. Hum Mol Genet 12(Spec No. 2): R125-R133.
50. Park IH, Park HJ, Chun JW, Kim EY, Kim JJ. 2008. Dysfunctional modulation of emotional interference in the medial prefrontal cortex in patients with schizophrenia. Neurosci Lett 440(2): 119-124.
51. Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE, Egan MF, Meyer-Lindenberg A, Weinberger DR. 2004. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 24(45): 10099-100102.
52. Pinkham AE, Hopfinger JB, Pelphrey KA, Piven J, Penn DL. 2008. Neural bases for impaired social cognition in schizophrenia and autism spectrum disorders. Schizophr Res 99(1-3): 164-175.
53. Pomarol-Clotet E, Salvador R, Sarro S, Gomar J, Vila F, Martinez A, Guerrero A, Ortiz-Gil J, Sans-Sansa B, Capdevila A, et al. 2008. Failure to deactivate in the prefrontal cortex in schizophrenia: Dysfunction of the default mode network? Psychol Med 38(8): 1185-1193.
54. Qian L, Zhao J, Shi Y, Zhao X, Feng G, Xu F, Zhu S, He L. 2007. Brain-derived neurotrophic factor and risk of schizophrenia: An association study and meta-analysis. Biochem Biophys Res Commun 353(3): 738-743.
55. Raichle ME, Snyder AZ. 2007. A default mode of brain function: A brief history of an evolving idea. Neuroimage 37(4): 1083-1090; discussion 1097-1099.
56. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. 2001. A default mode of brain function. Proc Natl Acad Sci USA 98(2): 676-682.
57. Reske M, Kellermann T, Habel U, Jon Shah N, Backes V, von Wilmsdorff M, Stocker T, Gaebel W, Schneider F. 2007. Stability of emotional dysfunctions? A long-term fMRI study in first-episode schizophrenia. J Psychiatr Res 41(11): 918-927.
58. Reske M, Habel U, Kellermann T, Backes V, Jon Shah N, von Wilmsdorff M, Gaebel W, Zilles K, Schneider F. 2009. Differential brain activation during facial emotion discrimination in first-episode schizophrenia. J Psychiatr Res 43(6): 592-599.
59. Rosa A, Cuesta MJ, Fatjo-Vilas M, Peralta V, Zarzuela A, Fananas L. 2006. The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: Evidence from a family-based association study. Am J Med Genet Part B 141B(2): 135-138.
60. Rybakowski JK, Borkowska A, Czerski PM, Skibinska M, Hauser J. 2003. Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disord 5(6): 468-472.
61. Rybakowski JK, Borkowska A, Skibinska M, Szczepankiewicz A, Kapelski P, Leszczynska-Rodziewicz A, Czerski PM, Hauser J. 2006. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene. Psychiatry Clin Neurosci 60(1): 70-76.
62. Schaufelberger M, Senhorini MC, Barreiros MA, Amaro E Jr, Menezes PR, Scazufca M, Castro CC, Ayres AM, Murray RM, McGuire PK, et al. 2005. Frontal and anterior cingulate activation during overt verbal fluency in patients with first episode psychosis. Rev Bras Psiquiatr 27(3): 228-232.
63. Segall JM, Turner JA, van Erp TG, White T, Bockholt HJ, Gollub RL, Ho BC, Magnotta V, Jung RE, McCarley RW, et al. 2009. Voxel-based morphometric multisite collaborative study on schizophrenia. Schizophr Bull 35(1): 82-95.
64. Shenton ME, Dickey CC, Frumin M, McCarley RW. 2001. A review of MRI findings in schizophrenia. Schizophr Res 49(1-2): 1-52.
65. Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G, Schaffner S, Kirov G, Jones I, Owen M, et al. 2002. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neurotrophic factor [see comment]. Mol Psychiatry 7(6): 579-593.
66. Spence SA, Liddle PF, Stefan MD, Hellewell JS, Sharma T, Friston KJ, Hirsch SR, Frith CD, Murray RM, Deakin JF, et al. 2000. Functional anatomy of verbal fluency in people with schizophrenia and those at genetic risk. Focal dysfunction and distributed disconnectivity reappraised. Br J Psychiatry 176: 52-60.
67. Steele JD, Lawrie SM. 2004. Segregation of cognitive and emotional function in the prefrontal cortex: A stereotactic meta-analysis. Neuroimage 21: 868-875.
68. Szeszko PR, Lipsky R, Mentschel C, Robinson D, Gunduz-Bruce H, Sevy S, Ashtari M, Napolitano B, Bilder RM, Kane JM, et al. 2005. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry 10(7): 631-636.
69. Takahashi M, Shirakawa O, Toyooka K, Kitamura N, Hashimoto T, Maeda K, Koizumi S, Wakabayashi K, Takahashi H, Someya T, et al. 2000. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol Psychiatry 5(3): 293-300.
70. Tan YL, Zhou DF, Cao LY, Zou YZ, Wu GY, Zhang XY. 2005. Effect of BDNF Val66Met genotype on episodic memory in schizophrenia. Schizophr Res 77(2-3): 355-356.
71. Thermenos HW, Seidman LJ, Breiter H, Goldstein JM, Goodman JM, Poldrack R, Faraone SV, Tsuang MT. 2004. Functional magnetic resonance imaging during auditory verbal working memory in nonpsychotic relatives of persons with schizophrenia: A pilot study. Biol Psychiatry 55(5): 490-500.
72. Thome J, Foley P, Riederer P. 1998. Neurotrophic factors and the maldevelopment hypothesis of schizophrenic psychoses. J Neural Transm 105: 85-100.
73. Tochigi M, Otowa T, Suga M, Rogers M, Minato T, Yamasue H, Kasai K, Kato N, Sasaki T. 2006. No evidence for an association between the BDNF Val66Met polymorphism and schizophrenia or personality traits. Schizophr Res 87(1-3): 45-47.
74. Torrey EF. 1992. Are we overestimating the genetic contribution to schizophrenia? Schizophr Bull 18(2): 159-170.
75. Varnas K, Lawyer G, Jonsson EG, Kulle B, Nesvag R, Hall H, Terenius L, Agartz I. 2008. Brain-derived neurotrophic factor polymorphisms and frontal cortex morphology in schizophrenia. Psychiatr Genet 18(4): 177-183.
76. Vita A, De Peri L, Silenzi C, Dieci M. 2006. Brain morphology in first-episode schizophrenia: A meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res 82(1): 75-88.
77. Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, Kleinman JE. 2003. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry 8(6): 592-610.
78. Whalley HC, Simonotto E, Flett S, Marshall I, Ebmeier KP, Owens DG, Goddard NH, Johnstone EC, Lawrie SM. 2004. fMRI correlates of state and trait effects in subjects at genetically enhanced risk of schizophrenia [see comment]. Brain 127(Pt 3): 478-490.
79. Whalley HC, Simonotto E, Marshall I, Owens DG, Goddard NH, Johnstone EC, Lawrie SM. 2005a. Functional disconnectivity in subjects at high genetic risk of schizophrenia. Brain 128(Pt 9): 2097-2108.
80. Whalley HC, Whyte MC, Johnstone EC, Lawrie SM. 2005b. Neural correlates of enhanced genetic risk for schizophrenia. Neuroscientist 11(3): 238-249.
81. Whalley HC, Simonotto E, Moorhead W, McIntosh A, Marshall I, Ebmeier KP, Owens DG, Goddard NH, Johnstone EC, Lawrie SM. 2006. Functional imaging as a predictor of schizophrenia. Biol Psychiatry 60(5): 454-462.
82. Whitfield-Gabrieli S, Thermenos HW, Milanovic S, Tsuang MT, Faraone SV, McCarley RW, Shenton ME, Green AI, Nieto-Castanon A, LaViolette P, et al. 2009. Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia [erratum appears in Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4572]. Proc Natl Acad Sci USA 106(4): 1279-1284.
83. Wing JK, Cooper JE, Sartorius N. 1974. The description and classification of psychiatric symptoms. An instruction manual for the PSE and Catego Systems. Cambridge: Cambridge University Press.
84. Witthaus H, Kaufmann C, Bohner G, Ozgurdal S, Gudlowski Y, Gallinat J, Ruhrmann S, Brune M, Heinz A, Klingebiel R, et al. 2009. Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls. Psychiatry Res 173(3): 163-169.
85. Yurgelun-Todd DA, Waternaux CM, Cohen BM, Gruber SA, English CD, Renshaw PF. 1996. Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production. Am J Psychiatry 153(2): 200-205.